B
Braidwell Portfolio holdings
AUM
$2.92B
This Quarter Return
+20.95%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.1B
AUM Growth
+$3.1B
(+14%)
Cap. Flow
+$365M
Cap. Flow
% of AUM
11.77%
Top 10 Holdings %
Top 10 Hldgs %
37.76%
Holding
89
New
16
Increased
13
Reduced
14
Closed
12
Top Buys
| 1 |
Apogee Therapeutics
APGE
|
$77.2M |
| 2 |
Viking Therapeutics
VKTX
|
$58.5M |
| 3 |
CG Oncology
CGON
|
$49.6M |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$45.1M |
| 5 |
Intuitive Surgical
ISRG
|
$40.1M |
Top Sells
| 1 |
Immunocore
IMCR
|
$41.8M |
| 2 |
Day One Biopharmaceuticals
DAWN
|
$33.7M |
| 3 |
Lantheus
LNTH
|
$30.7M |
| 4 |
Keros Therapeutics
KROS
|
$25.3M |
| 5 |
Harrow
HROW
|
$18.2M |
Sector Composition
| 1 | Healthcare | 57.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apogee Therapeutics
APGE
$2.17B
| $122M | 3.95% | 1,842,515 +1,161,414 | +171% | +$77.2M |
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $101M | 3.25% | 730,209 +15,000 | +2% | +$2.07M |
|
3
argenx
ARGX
$43.6B
| $86.5M | 2.79% | 219,824 +66,620 | +43% | +$26.2M |
|
4
Vaxcyte
PCVX
$4B
| $82.8M | 2.67% | 1,212,703 -77,262 | -6% | -$5.28M |
|
5
Legend Biotech
LEGN
$6.41B
| $69.8M | 2.25% | 1,243,795 +681,195 | +121% | +$38.2M |
|
6
Penumbra
PEN
$10.6B
| $66M | 2.13% | 295,892 +73,100 | +33% | +$16.3M |
|
7
Maravai LifeSciences
MRVI
$350M
| $62.6M | 2.02% | 7,221,960 +2,181,325 | +43% | +$18.9M |
|
|
8
Viking Therapeutics
VKTX
$3.04B
| $58.5M | 1.88% | +713,100 | New | +$58.5M |
|
9
Xenon Pharmaceuticals
XENE
$2.98B
| $56.3M | 1.81% | 1,308,011 -339,300 | -21% | -$14.6M |
|
10
iRhythm Technologies
IRTC
$5.46B
| $56.1M | 1.81% | 483,257 -84,900 | -15% | -$9.85M |
|
11
Align Technology
ALGN
$10.3B
| $55.5M | 1.79% | 169,252 +22,939 | +16% | +$7.52M |
|
12
Guardant Health
GH
$8.41B
| $51.1M | 1.65% | 2,476,804 +1,717,876 | +226% | +$35.4M |
|
|
13
CG Oncology
CGON
$2.04B
| $49.6M | 1.6% | +1,130,235 | New | +$49.6M |
|
|
14
Keros Therapeutics
KROS
$618M
| $48.8M | 1.57% | 737,379 -381,582 | -34% | -$25.3M |
|
15
Transmedics
TMDX
$3.92B
| $45.4M | 1.46% | 614,531 +496,830 | +422% | +$36.7M |
|
|
AVDL
16
Avadel Pharmaceuticals
AVDL
$1.43B
| $45.1M | 1.45% | +2,668,549 | New | +$45.1M |
|
17
Glaukos
GKOS
$5.5B
| $42.5M | 1.37% | 450,676 +207,916 | +86% | +$19.6M |
|
|
FNA
18
DELISTED
Paragon 28, Inc.
FNA
| $41.6M | 1.34% | 3,365,609 +3,785 | +0.1% | +$46.7K |
|
|
19
Intuitive Surgical
ISRG
$170B
| $40.1M | 1.29% | +100,500 | New | +$40.1M |
|
|
20
Day One Biopharmaceuticals
DAWN
$769M
| $35.9M | 1.16% | 2,173,704 -2,041,869 | -48% | -$33.7M |
|
21
4D Molecular Therapeutics
FDMT
$288M
| $33.5M | 1.08% | +1,052,485 | New | +$33.5M |
|
22
OrthoPediatrics
KIDS
$536M
| $32.3M | 1.04% | 1,107,770 | – | – |
|
23
Krystal Biotech
KRYS
$4.27B
| $31.5M | 1.02% | 177,089 -19,111 | -10% | -$3.4M |
|
24
Relay Therapeutics
RLAY
$619M
| $31.1M | 1% | +3,743,999 | New | +$31.1M |
|
25
Ironwood Pharmaceuticals
IRWD
$214M
| $30.4M | 0.98% | +3,489,843 | New | +$30.4M |
|